Risk factors
Ligand Pharmaceuticals (LGND) risk factors
Item 1A of every Ligand Pharmaceuticals Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors61 risks16 new4 dropped10 reworded
Ligand expanded risk disclosures around AI adoption, data privacy, key personnel dependencies, and ongoing exposure to Pelthos.
Filed Feb 27, 2026 - FY2024 10-K risk factors49 risks
Ligand relies heavily on royalty and material revenues from key partnered products like Kyprolis and Captisol.
Filed Feb 28, 2025